The US generic injectables market reached a value of US$ 13.7 Billion in 2020. Generic injectables refer to bioequivalents of branded drugs that are not protected by patents. They are used for rapidly transporting the drug into the body, bypassing the first-pass metabolism. Since they have a similar quality, dosage, strength, effect and active ingredient, generic injectables are as safe and effective as innovator injectables. They are widely used in the United States on account of the rise in the prevalence of lifestyle ailments due to sedentary lifestyles, non-nutritive diet and aging population. They are utilized in the treatment of diseases such as cancer, diabetes, osteoporosis, osteoarthritis, rheumatoid arthritis, respiratory and cardiovascular disorders.
The US is witnessing a rise in the demand for generic injectables on account of increasing investment by the US Government for the development of generic drugs. It is focusing on promoting generic injectables to reduce healthcare expenditure in the country. Further, drug shortages in confluence with speedy approvals by the USFDA are expected to boost the manufacturing of these drugs. Moreover, several branded injectables firms are also anticipated to lose their patient protection in the upcoming years, thereby offering numerous remunerative opportunities to the generic injectables manufacturers. Looking forward, the analyst expects the US generic injectables market to grow at a CAGR of 6.8% during the forecast period (2021-2026).
The report finds that the oncology segment exhibits dominance in the market as injectables are used to treat different types of cancers. It is followed by anti-infectives, cardiovascular, parenteral nutrition and anesthesia.
Breakup by Containers: Vials Ampoules Premix Prefilled Syringes
Currently, vials account for the majority of the total market share as they are flexible, easy to dispose of and cost-effective. They are followed by premix, prefilled syringes and ampoules.
Breakup by Distribution Channel: Hospitals Retail Pharmacy
At present, hospitals represent the largest segment as the injectables for oncology, anesthesia, and anti-infectives cannot be administrated without medical assistance.
Competitive Landscape: The market is highly concentrated in nature with the presence of only a few top manufacturers who compete against one another in terms of prices and quality.
Along with this, the analyst has also done a study on the global generic injectables market, which has enabled our clients to set up and expand their businesses successfully.
Key Questions Answered in this Report: How has the US generic injectables market performed so far and how will it perform in the coming years? What are the major therapeutic areas in the US generic injectables industry? What has been the impact of COVID-19 on the US generic injectables industry? What are the several containers used in the US generic injectables industry? What are the major distribution channels in the US generic injectables industry? What are the various stages in the value chain of the US generic injectables industry? What are the key driving factors and challenges in the US generic injectables industry? What is the structure of the US generic injectables industry and who are the key players? What is the degree of competition in the US generic injectables industry? What are the profit margins in the US generic injectables industry? What are the key requirements for setting up generic injectables manufacturing plant? How are generic injectables manufactured? What are the various unit operations involved in generic injectables manufacturing plant? What is the total size of land required for setting up generic injectables manufacturing plant? What are the machinery requirements for setting up generic injectables manufacturing plant? What are the raw material requirements for setting up generic injectables manufacturing plant? What are the packaging requirements for generic injectables? What are the transportation requirements for generic injectables? What is the time required to break-even?
Our reports have been used by over 10K customers, including:
The global people counting system market is projected to reach USD 1.4 billion by 2026 from an estimated USD 0.9 billion in 2021, at a CAGR of 9.4% from 2021 to 2026. The incorporation of people counting system for end users such as retail stores, supermarkets, and shopping malls, and transportation are among the factors driving the growth...
Europe specialty generics market reached a value of US$ 16.4 Billion in 2020. Specialty generics are classified as high-cost, high complexity and/or high touch generics. They are the generic versions of speciality branded drugs after they lose their patent protection. Specialty generics are used to treat complex diseases which may be chronic...
2021 Orthopedics Market Analysis, Global Forecasts, Competitive Landscape--Accelerated Rate of Change and Regulatory Uncertainty--Performance, Capabilities, Goals and Strategies of Leading Suppliers I. Top 10 Orthopedic Companies Aesculap, Arthrex, DePuy Synthes, Globus Medical, Medtronic,...
The ablation technology market is projected to reach USD 8.1 Billion by 2026 from USD 5.2 Billion in 2021, at a CAGR of 9.3% during the forecast period. The growing elderly population has also driven the incidence of target conditions and contributed to the demand for effective treatment. However, the reuse and reprocessing of devices in developed...
299 pages •
By Global Industry Analysts
• Aug 2021
Abstract: Global Rheumatoid Arthritis Diagnosis Tests Market to Reach $766.7 Million by 2026 Rheumatoid Arthritis (RA), a chronic autoimmune disease, causes inflammation in the joints, muscles, connective tissues, fibrous tissues, and tendons causing pain and swelling. The disease is developed...
The N95 masks market is projected to reach US$ 4,925.80 million by 2028 from US$ 1,914.54 million in 2021; it is expected to grow at a CAGR of 14.5% from 2021 to 2028. Prevalence of COVID-19 and increasing investments and initiatives by market players, and governments drive the growth of the N95 masks market. However, the availability...
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Autonomous Floor Scrubber Market Report The global autonomous floor scrubber market is expected to reach 1476.26 million USD by 2026, growing at a CAGR of 12.35% during the forecast period 2021-2026 The following factors are likely...
The global revenue cycle management market is projected to reach USD 67.8 billion by 2026 from USD 40.9 billion in 2021, at a CAGR of 10.6% during the forecast period. The growth of this market is majorly attributed to the growing regulatory requirements & government initiatives to boost the adoption of RCM solutions, increasing patient volumes,...
The healthcare analytical testing services market is projected to reach USD 9.8 billion by 2026 from USD 5.6 billion in 2021, at a CAGR of 11.9%. Growth in the market is driven by the rising trend of outsourcing of analytical testing by pharmaceutical companies and medical device companies, an increasing number of clinical trials, and the...
175 pages •
By The Business Research Company
• Sep 2021
Major players in the healthcare e-commerce market are Amazon, Exactcare Pharmacy, Flipkart Pvt. Ltd., Alibaba Group Holding Ltd., eBay Inc., Remdi SeniorCare, Lloyds Pharmacy Ltd., McCabes Pharmacy, Walgreens Boots Alliance Inc., and CVS Health. The global healthcare e-commerce market is expected to decline from $352.23 billion in 2020...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.